Clinical Trial

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

Study acronym: APR
Recruiting
View on ClinicalTrials.gov →
Summary
The Alzheimer's Prevention Registry (www.endALZnow.org) will collect contact and demographic information on individuals. The objective is to provide information the latest news and advances in Alzheimer's prevention research, and to inform enrollees about research studies in their community. Enrolled individuals will receive regular email communications. As research studies become available, individuals will be notified via email with information as to how proceed should they be interested. Registry enrollees are under no obligation to participate in a research study. Study opportunities may include surveys, healthy lifestyle interventions (e.g., diet, exercise), memory \& thinking tests, brain scans, and investigational drug trials. To join the Registry, please visit www.endALZnow.org
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2013-12-23; most recent amendment 2025-12-08.
Trial Details
NCT Number NCT02022943
Lead Sponsor Banner Health
Conditions Alzheimer's Disease, Dementia
Enrollment 500,000 participants
Start Date 2012-05
Primary Completion 2030-01 (estimated)
Study Completion 2030-01 (estimated)
Updated on ClinicalTrials.gov 2025-12-16